missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-17A/F Heterodimer Biotin Protein
Click to view available options
:
25μg; Biotin
Beschreibung
The Recombinant Human IL-17A/F Heterodimer Biotin Protein is derived from CHO. The Recombinant Human IL-17A/F Heterodimer Biotin Protein has been validated for the following applications: Bioactivity.
Spezifikation
Spezifikation
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Gen-ID (Entrez) | 3605 |
| Molekulargewicht | Theoretical M.W.: 15kDa (unlabeled IL-17A), 15kDa (unlabeled IL-17F) |
| Menge | 25μg |
| Quelle | Chinese Hamster Ovary cell line,CHO-derived human IL-17A/F Heterodimer protein, (N-terminus) Human IL-17A (Gly24-Ala155) Accession &Num; Q16552 Human IL-17F (Arg21-GLN163) Accession &Num; Q96PD4 (C-terminus) |
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Endotoxin-Konzentration | <1.0 EU per 1μg of the protein by the LAL method. |
| Gen-Alias | CTLA8, CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, Cytotoxic T-Lymphocyte-Associated Protein 8, IL17, IL-17, IL-17A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17A, interleukin-17A |
| Gebräuchliche Bezeichnung | IL-17A/F Heterodimer |
| Biologische Aktivität | Measured by its ability to induce IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells. The ED50 for this effect is typically 0.4-2ng/mL. |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur